Clinical trial
L-Arginine Metabolism in Essential Hypertension
NCT00137124 · University of Erlangen-Nürnberg Medical School, Other · Completed
Key facts
| NCT number | NCT00137124 |
|---|---|
| Title | L-Arginine Metabolism in Essential Hypertension |
| Official title | Transport and Metabolism of L-arginine: Role for Endothelial Dysfunction in Essential Hypertension |
| Lead sponsor | University of Erlangen-Nürnberg Medical School, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Essential Hypertension |
| Intervention type | Drug |
| Interventions | L-Arginine |
| Enrollment | 120 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Aug 29, 2005 |
| Last update posted | Jul 10, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: